Involvement of the N-Terminal Deubiquitinating Protease Domain of Human Cytomegalovirus UL48 Tegument Protein in Autoubiquitination, Virion Stability, and Virus Entry

Journal of Virology
Young-Eui KimJin-Hyun Ahn

Abstract

Human cytomegalovirus (HCMV) protein pUL48 is closely associated with the capsid and has a deubiquitinating protease (DUB) activity in its N-terminal region. Although this DUB activity moderately increases virus replication in cultured fibroblast cells, the requirements of the N-terminal region of pUL48 in the viral replication cycle are not fully understood. In this study, we characterized the recombinant viruses encoding UL48(ΔDUB/NLS), which lacks the DUB domain and the adjacent nuclear localization signal (NLS), UL48(ΔDUB), which lacks only the DUB, and UL48(Δ360-1200), which lacks the internal region (amino acids 360 to 1200) downstream of the DUB/NLS. While ΔDUB/NLS and Δ360-1200 mutant viruses did not grow in fibroblasts, the ΔDUB virus replicated to titers 100-fold lower than those for wild-type virus and showed substantially reduced viral gene expression at low multiplicities of infection. The DUB domain contained ubiquitination sites, and DUB activity reduced its own proteasomal degradation in trans. Deletion of the DUB domain did not affect the nuclear and cytoplasmic localization of pUL48, whereas the internal region (360-1200) was necessary for cytoplasmic distribution. In coimmunoprecipitation assays, pUL48 intera...Continue Reading

References

Jan 1, 2000·Archives of Pharmacal Research·J J HyunH J Kim
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Dong YuThomas Shenk
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Walter DunnFenyong Liu
Nov 25, 2005·Journal of Virology·Christian SchliekerHidde L Ploegh
Dec 15, 2005·Journal of Virology·G W Gant LuxtonGregory Allan Smith
Aug 24, 2007·Journal of Virology·Kelly Elizabeth CollerGregory Allan Smith
Jan 25, 2008·Journal of Virology·Vladimir JovasevicBernard Roizman
Jun 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Robert F Kalejta
Jun 7, 2008·Nature Reviews. Immunology·Shao-Cong Sun
Oct 24, 2008·Journal of Virology·Shelley K CockrellFred L Homa
Oct 22, 2010·Journal of Virology·Stacia L Phillips, Wade A Bresnahan
May 29, 2012·Trends in Microbiology·Ritesh Tandon, Edward S Mocarski
Feb 19, 2013·Cell Host & Microbe·Sofia V ZaichickGregory A Smith
Sep 27, 2015·Proceedings of the National Academy of Sciences of the United States of America·Nicholas J HuffmasterGregory A Smith

❮ Previous
Next ❯

Citations

May 8, 2020·Journal of Virology·Rinki KumarNicholas J Buchkovich
Aug 9, 2020·Frontiers in Microbiology·Yu-Qing Wang, Xiang-Yu Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.